HLA-class I tetramers were used to analyze CD8+ cells from patients with AHA, revealing the activation of both HAV-specific CD8+ T cells and HAV-unrelated virus-specific CD8+ T cells. This evidence concerns the gene CD8A and autoimmune hemolytic anemia.